Evolocumab (trade name Repatha) is a monoclonal antibody medication designed for the treatment of hyperlipidemia. Evolocumab is a fully human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9). PCSK9 is a protein that targets LDL receptors for degradation and its inhibition thereby enhances the liver's ability to remove LDL-C, or "bad" cholesterol, from the … Web4 mrt. 2024 · I developed unusual weak feeling in large muscles, like hypoglycemia. This then turned into a flu-like state, or very bad hangover. Then came burning bladder, …
Repatha (evolocumab) — Werking & Bijwerkingen - Simpto.nl
WebSummary: Diabetes is found among people who take Repatha, especially for people who are female, 60+ old, have been taking the drug for 6 - 12 months. The phase IV clinical … WebRepatha wordt gebruikt in combinatie met een statine of in combinatie met een statine en andere vetverlagende geneesmiddelen. Repatha kan bij patiënten die geen statines … how does the rhetorical triangle work
Repatha® (evolocumab) Mechanism of Action (MOA) - Amgen, Inc
WebThe efficacy of REPATHA was investigated in three double-blind, placebo-controlled trials that included 764 patients with atherosclerotic cardiovascular disease (ASCVD) and … Web17 sep. 2024 · Repatha (evolocumab) Injection is a human monoclonal immunoglobulin G2 (IgG2) as an adjunct to diet and maximally tolerated statin therapy for the treatment of … Web31 jul. 2024 · Summary. The pathway of marijuana in our body can be split into 3 phases: Consumption – this is what happens when we consume weed. Metabolism – this is how … how does the rhythm method work